Poland· PL-100099917
Perazin 25 mg
A perazine product containing perazinum, registered in Poland by Przedsiębiorstwo Produkcji Farmaceutycznej HASCO-LEK S.A.. The same ATC class is registered in 2 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Perazine is registered in 2 of 19 countries.
Countries holding a registration under ATC N05AB10 (perazine), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 2 of them publish a price we can compare per daily dose
Perazine · ATC N05AB10
2 / 19 countries
- Norwayprice
- Polandprice
The record
At a glance
URPL (Poland)- Active substance
- Perazinum
- Manufacturer
- Przedsiębiorstwo Produkcji Farmaceutycznej HASCO-LEK S.A.
- Country
- Poland (PL)
- ATC code
- N05AB10
- ATC class
- Perazine
- Defined daily dose
- 0.1 g, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 3
2 priced- gtin0590999085841520 szt.PLN 3.65
- gtin0590999091483850 szt.PLN 5.26
- gtin05904055003274
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under N05AB10
Perazine, as other registers publish it.
- PolandPerazin 100 mgPrzedsiębiorstwo Produkcji Farmaceutycznej HASCO-LEK S.A.
- PolandPerazin 200 mgPrzedsiębiorstwo Produkcji Farmaceutycznej HASCO-LEK S.A.
- PolandPerazin 50 mgPrzedsiębiorstwo Produkcji Farmaceutycznej HASCO-LEK S.A.
- NorwayPernazinumLabor L + S AG
- PolandPernazinumLabor Przedsiębiorstwo Farmaceutyczno-Chemiczne Sp. z o.o.
- PolandPernazinumLabor Przedsiębiorstwo Farmaceutyczno-Chemiczne Sp. z o.o.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fd312917-b789-4e16-9b50-85d7b5ec6e89 GET /v1/drugs/fd312917-b789-4e16-9b50-85d7b5ec6e89?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki",
"source": "urpl",
"strength": "25 mg",
"packaging": "05909990858415 ¦ Rp ¦ 17137\n20 tabl.\n05909990914838 ¦ Rp ¦ 70806\n50 tabl.\n05904055003274 ¦ Rp ¦ 82846\n30 tabl.",
"substance": "Perazini dimaleas 42.1 mg",
"common_name": "Perazinum",
"pl_product_id": "100099917",
"pozwolenie_nr": "08584",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about perazine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.